BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners
Description: Innovations in manufacturing processes, more complicated formulations, and increasingly complex global supply chains are just some of the factors making it more difficult for companies to assess and control impurities in drug substances and drug products. BOC Sciences is confident to employ its custom manufacturing capabilities and make large-scale impurities available to advance the development of analytical methods.
